Phase 2 study

Recruiting Phase 2

Sources: ClinicalTrials.gov Checked: 11 October 2026 Not medical advice

This trial at a glance

Status Recruiting
Phase Phase 2
Sponsor Sanofi
Registry number NCT07810010
Started 9 September 2026 Today 16 October 2026 Estimated completion 3 July 2028

Where this trial is running

Trial sites and the status recorded for each
SiteCityState or countryStatus at this site
Investigational Site Number : 0360008 Bruse ACT Recruiting
Investigational Site Number : 0360006 Blacktown NSW Recruiting
Investigational Site Number : 0360007 Maroubra NSW Recruiting
Investigational Site Number : 0360002 Albion QLD Recruiting
Investigational Site Number : 0360003 Sippy Downs QLD Recruiting
Investigational Site Number : 0360009 Melbourne VIC Recruiting

voxsanity.com.au · trial sites from public registries · registry record synced 11 October 2026 · not medical advice

Who can join

Age 60 Years and over
Sex Anyone, regardless of sex
Healthy volunteers Accepted
Enrolment target 8000

The official eligibility criteria

Registry text, reproduced exactly. These are the words the trial's sponsor published on ClinicalTrials.gov. They have not been edited, shortened or rewritten, and they are written for researchers rather than for patients.

Inclusion Criteria:

* Aged 60 years or older on the day of inclusion

* Participants who, as determined by medical evaluation including medical history, physical examination, and clinical judgment of the Investigator are eligible for inclusion

Exclusion Criteria:

* Known/suspected immunodeficiency; immunosuppressive therapy/immunomodulators in past 6 months; long-term systemic corticosteroids (eg, prednisone for more than 2 weeks in past 3 months); history of immune-mediated neurological disease. Of note, persons living with stable HIV are not excluded

* Known systemic hypersensitivity to any of the study intervention components or history of a life-threatening reaction to the study interventions used in the study or to a product containing any of the same substances

* Chronic illness that, in the opinion of the investigator, is at a stage where it might interfere with study conduct or completion

* Previous history of Guillain-Barré Syndrome (GBS)

* Previous vaccination against RSV and/or HMPV (with a licensed or investigational vaccine either as a monovalent vaccine or any combination of the antigens) or previous receipt of RSV and/or HMPV monoclonal antibody

The above information is not intended to contain all considerations relevant to a participant's potential participation in a clinical trial.

Dates on the record

Started 9 September 2026
Estimated completion 3 July 2028
Registry last updated 16 September 2026
Checked by Voxsanity 11 October 2026

Results, publications and the official record

Sources and dates

  • ClinicalTrials.gov – the record this page reformats
  • ClinicalTrials.gov processing date: 16 September 2026.
  • This page last checked by Voxsanity: 11 October 2026.

Voxsanity reformats data from public registries into this layout. It does not edit, interpret or add to what the registry published.

Not medical advice.

Individual trial records are refreshed on a rolling basis rather than all at once, so a record may be up to several weeks old. Each trial page and trial card shows the date its own record was last synced. Where a record has lagged, its status, sites and enrolment can differ from the current registry state in either direction, so check the registry link on the trial page before acting on them.

Letter for your doctor

A one-page summary of this trial to print or email to your GP. It carries the registry's own record of the trial and its eligibility criteria, and nothing Voxsanity has written about whether it suits you.